造血集落刺激因子使用建议的1997年更新：循证临床实践指南。美国临床肿瘤学会。 - Suppr | 超能文献

1997 update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines. American Society of Clinical Oncology.

出版信息

J Clin Oncol. 1997 Oct;15(10):3288. doi: 10.1200/JCO.1997.15.10.3288.

DOI:10.1200/JCO.1997.15.10.3288

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

1997 update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines. American Society of Clinical Oncology.造血集落刺激因子使用建议的1997年更新：循证临床实践指南。美国临床肿瘤学会。

J Clin Oncol. 1997 Oct;15(10):3288. doi: 10.1200/JCO.1997.15.10.3288.

2

Update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based clinical practice guidelines. American Society of Clinical Oncology.造血集落刺激因子使用建议更新：循证临床实践指南。美国临床肿瘤学会。

J Clin Oncol. 1996 Jun;14(6):1957-60. doi: 10.1200/JCO.1996.14.6.1957.

3

2000 update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines. American Society of Clinical Oncology Growth Factors Expert Panel.造血集落刺激因子使用建议的2000年更新：循证临床实践指南。美国临床肿瘤学会生长因子专家小组。

J Clin Oncol. 2000 Oct 15;18(20):3558-85. doi: 10.1200/JCO.2000.18.20.3558.

4

American Society of Clinical Oncology. Recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines.美国临床肿瘤学会。造血集落刺激因子使用建议：循证临床实践指南。

J Clin Oncol. 1994 Nov;12(11):2471-508. doi: 10.1200/JCO.1994.12.11.2471.

5

Impact of American Society of Clinical Oncology guidelines for clinical use of colony-stimulating factors.

J Clin Oncol. 1999 Oct;17(10):3360-1. doi: 10.1200/JCO.1999.17.10.3360.

6

The use of myeloid colony-stimulating factors in hematologic malignancies: the role of systematic reviews and meta-analyses.髓系集落刺激因子在血液系统恶性肿瘤中的应用：系统评价和荟萃分析的作用。

Acta Haematol. 2011;125(1-2):68-79. doi: 10.1159/000318898. Epub 2010 Dec 8.

7

The relationship between introduction of American society of clinical oncology guidelines and the use of colony-stimulating factors in clinical practice in a Paris university hospital.美国临床肿瘤学会指南的引入与巴黎一家大学医院临床实践中集落刺激因子使用之间的关系。

Clin Ther. 2001 Jul;23(7):1116-27. doi: 10.1016/s0149-2918(01)80095-3.

8

Use of hematopoietic colony-stimulating factors: the American Society of Clinical Oncology survey. The Health Services Research Committee of the American Society of Clinical Oncology.造血集落刺激因子的使用：美国临床肿瘤学会调查。美国临床肿瘤学会卫生服务研究委员会。

J Clin Oncol. 1996 Sep;14(9):2511-20. doi: 10.1200/JCO.1996.14.9.2511.

9

[Colony-stimulating factors].

Med Monatsschr Pharm. 1990 Jun;13(6):162-4.

10

Clinical applications of colony-stimulating factors.

Oncology (Williston Park). 1988 Jan;2(1):15-23.

引用本文的文献

1

Granulocyte colony--stimulating factor for chemotherapy-induced neutropenia in patients with small cell lung cancer : the 40% rule revisited.粒细胞集落刺激因子用于小细胞肺癌患者化疗所致中性粒细胞减少症：重新审视40%规则

Pharmacoeconomics. 2005;23(8):767-75. doi: 10.2165/00019053-200523080-00003.

2

Management of chemotherapy-induced adverse effects in the treatment of colorectal cancer.结直肠癌治疗中化疗引起的不良反应的管理

Drug Saf. 2001;24(5):353-67. doi: 10.2165/00002018-200124050-00002.

3

Severe neutropenia: a diagnostic approach.严重中性粒细胞减少症：一种诊断方法。

West J Med. 2000 Apr;172(4):248-52. doi: 10.1136/ewjm.172.4.248.